Nina Harawa

Dr. Nina Harawa


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1999 in Epidemiology
Verified
Journal Article
Closed access
RHRobert W. Haile
Robert W. Haile
JWJohn S. Witte
John S. Witte
MGMark Gold
Mark Gold
RCRon Cressey
Ron Cressey
CMCharles McGee
Charles McGee
GWGuang-Yu Wang
Guang-Yu Wang
Waters adjacent to the County of Los Angeles (CA) receive untreated runoff from a series of storm drains year round. Many other coastal areas face a similar situation. To our knowledge, there has not been a large-scale epidemiologic study of persons who swim in marine waters subject to such runoff. We report here results of a cohort study conducted to investigate this issue. Measures of exposure included distance from the storm drain, selected bacterial indicators (total and fecal coliforms, enterococci, and Escherichia coli), and a direct measure of enteric viruses. We found higher risks of a broad range of symptoms, including both upper respiratory and gastrointestinal, for subjects swimming (a) closer to storm drains, (b) in water with high levels of single bacterial indicators and a low ratio of total to fecal coliforms, and (c) in water where enteric viruses were detected. The strength and consistency of the associations we observed across various measures of exposure imply that there may be an increased risk of adverse health outcomes associated with swimming in ocean water that is contaminated with untreated urban runoff.

1 July 2010 in Social Science & Medicine
Verified
Journal Article
Closed access
CFChandra Ford
Chandra Ford
NHNina Harawa
Nina Harawa

1 April 2004 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
NHNina Harawa
Nina Harawa
SGSander Greenland
Sander Greenland
TBTrista A. Bingham
Trista A. Bingham
DJDenise F. Johnson
Denise F. Johnson
SCSusan D. Cochran
Susan D. Cochran
LVLucia A. Valleroy
Lucia A. Valleroy
Using data from a multisite venue-based survey of male subjects aged 15 to 22 years, we examined racial/ethnic differences in demographics, partner type, partner type-specific condom use, drug use, and HIV prevalence in 3316 US black, multiethnic black, Latino, and white men who have sex with men (MSM). We further estimated associations of these factors with HIV infection and their influence on racial/ethnic disparities in HIV prevalence. HIV prevalences were 16% for both black and multiethnic black participants, 6.9% for Latinos, and 3.3% for whites. Paradoxically, potentially risky sex and drug-using behaviors were generally reported most frequently by whites and least frequently by blacks. In a multiple logistic regression analysis, positive associations with HIV included older age, being out of school or work, sex while on crack cocaine, and anal sex with another male regardless of reported condom use level. Differences in these factors did not explain the racial/ethnic disparities in HIV prevalence, with both groups of blacks experiencing more than 9 times and Latinos experiencing approximately twice the fully adjusted odds of infection compared with whites. Understanding racial/ethnic disparities in HIV risk requires information beyond the traditional risk behavior and partnership type distinctions. Prevention programs should address risks in steady partnerships, target young men before sexual initiation with male partners, and tailor interventions to men of color and of lower socioeconomic status.

1 January 2012 in Journal of the National Medical Association
Verified
Journal Article
Closed access
ODO. Kenrik Duru
O. Kenrik Duru
NHNina Harawa
Nina Harawa
DKDulcie Kermah
Dulcie Kermah
KNKeith C. Norris
Keith C. Norris

1 February 2003 in AIDS Education and Prevention
Verified
Journal Article
Closed access
TBTrista A. Bingham
Trista A. Bingham
NHNina Harawa
Nina Harawa
DJDenise F. Johnson
Denise F. Johnson
GSGina M. Secura
Gina M. Secura
DMDuncan A. MacKellar
Duncan A. MacKellar
LVLinda A. Valleroy
Linda A. Valleroy

2 January 2001 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
EDEric S. Daar
Eric S. Daar
SLSusan Little
Susan Little
JPJacqui Pitt
Jacqui Pitt
JSJoanne Santangelo
Joanne Santangelo
PHPauline Ho
Pauline Ho
FNFor The Los Angeles County Primary Hiv Infection Recruitment Network
For The Los Angeles County Primary Hiv Infection Recruitment Network
The optimal approach for diagnosing primary HIV-1 infection has not been defined. To determine the usefulness of symptoms and virologic tests for diagnosing primary HIV-1 infection. Prospective cohort study. A teaching hospital in Los Angeles and a university research center in San Diego, California. 436 patients who had symptoms consistent with primary HIV infection. Clinical information and levels of HIV antibody, HIV RNA, and p24 antigen. Primary infection was diagnosed in 54 patients (12.4%). The sensitivity and specificity of the p24 antigen assay were 88.7% (95% CI, 77.0% to 95.7%) and 100% (CI, 99.3% to 100%), respectively. For the HIV RNA assay, sensitivity was 100% and specificity was 97.4% (CI, 94.9% to 98.9%). Fever, myalgia, rash, night sweats, and arthralgia occurred more frequently in patients with primary infection (P < 0.05). No sign or symptom allows targeted screening for primary infection. Although assays for HIV RNA are more sensitive than those for p24 antigen in diagnosing primary infection, they are more expensive and are more likely to yield false-positive results. *For participants in the Los Angeles County Primary HIV Infection Recruitment Network, see Appendix.